Brief Intervention and Fibroscan for Harmful Drinkers Presenting to the Emergency Department
Launched by NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST · Feb 7, 2023
Trial Information
Current as of May 15, 2025
Unknown status
Keywords
ClinConnect Summary
Alcohol Use Disorder (AUD) poses a significant burden to individuals, the population and the health and social care system in the United Kingdom (UK). Chronic liver disease is now the third most common cause of death and costs the National Health Service (NHS) an estimated £3.5 billion per year. This equates to 3.6% of the total NHS budget. The only effective way to reduce the risk of liver damage for people at high risk is to abstain from drinking alcohol. Alcohol services can successfully help people reduce their risk of liver damage by helping them reduce or stop drinking. Many people wi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Has capacity to give informed consent
- • Have no urgent or life-threatening illness or injury
- • Have not eaten a larger meal within 3 hours of trial enrollment
- • Answer "yes" to a single item alcohol screening question (standard care)
- • Score of 11 or 12 on the Audit-C alcohol screening tool
- Exclusion Criteria:
- • They are unable or unwilling to undertake single-question screening (standard care)
- • They refuse or lack capacity to give informed consent to trial inclusion
- • They are living in postcodes outside of the catchment areas for Nottingham City or Nottingham County community alcohol treatment services
- • They have an urgent or life-threatening illness or injury
- • Their treating clinician thinks there is any other reason that they would not benefit from trial inclusion
About Nottingham University Hospitals Nhs Trust
Nottingham University Hospitals NHS Trust is a leading healthcare provider in the UK, dedicated to delivering high-quality patient care and advancing medical research. Comprising two major hospitals, Queen's Medical Centre and Nottingham City Hospital, the Trust is at the forefront of clinical innovation and education. With a strong emphasis on translational research, Nottingham University Hospitals NHS Trust actively sponsors clinical trials aimed at improving treatment outcomes and understanding various health conditions. The Trust collaborates with academic institutions, healthcare professionals, and industry partners to foster a robust research environment that enhances clinical practice and contributes to evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, Nottinghamshire, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials